Font Size   A   A   A


Ferguson J, Sanderson B. Drug Phototoxicity - a Burning Issue in Drug Development? Journal for Clinical Studies 2011; 3(2), 40 - 44.

Moseley H, Ferguson J. Which light source should be used for the investigation of clinical phototoxicity: monochromator or solar simulator? Photoderm Photoimmunol Photomed 2010; 26: 3-6.

Bowen CJ, Lobb KM, Park JW, Sanderson B, Ferguson J. Eltrombopag (75 mg) does not induce photosensitivity: results of a clinical pharmacology trial. Photoderm Photoimmunol Photomed 2010; 26: 243-249.

Moseley H, Naasan H, Dawe R, Woods J, Ferguson. Population reference intervals for minimal erythemal doses in monochromator phototesting. Photoderm Photoimmunol Photomed 2009; 25: 8-11.

Kerr A, Woods J, Ferguson J. Photocontact allergic and phototoxic studies of chlorproethazine. Photodermatol Photoimmunol Photomed 2008; 24: 11-15.

BS 8497-1:2008; BS 8497-2:2008. Eyewear for Protection Against Intense Light Sources Used in Humans and Animals for Cosmetic and Medical Applications. (H. Moseley – Chairman of Committee). British Standards Institution. Part 1: Specification for Products; Part 2 User Guide, 2008.

Lain S, Hollick JJ, Campbell J, Staples O, Higgins M, Aoubala M, McCarthy A, Appleyard V, Murray KE. Baker L, Thompson A, Mathers J, Holland, SJ, Stark MJR, Pass G, Woods J, Lane DP, Westwood NJ. Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell 2008; 13: 1-10.

Mackay FS, Woods JA, Heringova P, Kasparkova J, Pizarro AM, Moggach SA, Parsons S, Brabec V, Sadler PJ. A potent cytotoxic photoactivated platinum complex. Proceedings of the National Academy of Sciences, 2007.

Ferguson J, DeLeo VA. Drug and chemical photosensitivity: exogenous. In: Lim HW, Honigsmann H, Hawk JLM, editors. Photodermatology. New York: Informa Healthcare; 2007, pp199-217.

Moseley H. Elementary photobiology and practical photophysics. In Ferguson J, Dover J, editors. Photodermatology. London, Manson Publishing, 2006, pp9-13.

Moseley H. Phototest equipment. In Ferguson J, Dover J, editors. Photodermatology. London, Manson Publishing, 2006, pp14-20.

Moseley H. Photoprotection. In Ferguson J, Dover J, editors. Photodermatology. London: Manson Publishing, 2006, pp21-28.

Ferguson J. Drug-induced photosensitivity. In: Ferguson J, Dover J, editors. Photodermatology. London, Manson Publishing, 2006, pp66-71.

Envall J, Ylianttila L, Moseley H, Coleman A, Durak M, Karha P, Ikonen E. Investigation of comparison methods for UVA irradiance responsivity calibration facilities. Metrologia 2006; 43: S27-S30.

Bryden AM, Moseley H, Ibbotson SH, Chowdhury MMU, Beck MH, Bourke J, English J, Farr P, Foulds, IS, Gawkrodger DJ, George S, Orton DI, Shaw S, McFadden J, Norris P, Podmore P, Powell, S, Rhodes LE, Sansom J, Wilkinson, M, van Weelden H, Ferguson J. Photopatch testing of 1155 patients: results of the U.K. multicentre photopatch study group. Br J Dermatol 2006; 155: 737-747.

Heringova P, Woods J, Mackay FS, Kasparkova J, Sadler PJ, Brabec V.

Transplatin is cytotoxic when photoactivated: Enhanced formation of DNA cross-Links J Medicinal Chem 2006; 49: 7792-7798.

Moseley H, Ibbotson S, Woods J, Brancaleon L, Lesar A, Goodman C, Ferguson J. Clinical and research applications of photodynamic therapy in dermatology: experience of the Scottish PDT Centre. Lasers Surg Med 2006; 38: 403-416.

Mackay S, Woods JA, Moseley H, Ferguson J, Dawson A, Parsons S, Sadler .J. A photoactivated trans-diammine platinum complex as cytotoxic as cisplatin.

Chemistry: A European Journal 2006; 12: 3155-3161.

Moseley H. Light distribution and calibration of commercial PDT LED arrays. Photochem Photobiol Sci 2005; 4: 911-914.

Moseley H. UVA dosimetry in photopatch test centres in Europe. J Eur Acad Dermatol Venereol 2005; 19: 187-190.

Dawe RS, Ibbotson SH, Sanderson JB, Thomson EM, Ferguson J. A randomised controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity. Br J Dermatol 2003; 149: 1232-1241.

Ferguson J. Phototoxicity due to fluoroquinolones. In: Hooper DC, Rubinstein E, editors. Quinolone Antimicrobial Agents, 3rd ed. Washington, DC: ASM Press; 2003, pp449-458.

Gies P, Roy C, McLennan A, Pailthorpe M, Hilfiker R, Osterwalder U, Monard B, Moseley H, Sliney D, Wengraitis S, Wong J, Human S, Bilimis Z, Holmes G. Ultraviolet protection factors for clothing: an intercomparison of measurement systems. Photochem Photobiol 2003; 77: 58-67.

Oliver H, Moseley H. The use of diode array spectroradiometers for dosimetry in phototherapy. Phys Med Biol 2002; 47: 4411-4421.

Moseley H, Cameron H, MacLeod T, Clark C, Dawe R, Ferguson J. New sunscreens confer improved protection for photosensitive patients in the blue light region. Br J Dermatol 2001; 145: 789-794.

Moseley H. Scottish UV dosimetry guidelines. Photoderm Photoimmunol Photomed 2001; 17: 230-233.

Ferguson J. Phototoxic drug reactions in man. MD Thesis, University of Dundee, 2000.

Ferguson J, McEwen J, Al-Ajmi H, Purkins L, Colman PJ, Willavize SA. A comparison of the photosensitizing potential of trovafloxacin with that of other quinolones in healthy subjects. J Antimicrob Chemother 2000; 45: 503-509.

Traynor NJ, Barrat MD, Lovell WW, Ferguson J, Gibbs NK. Comparison of an in vitro cellular phototoxicity model against controlled clinical trials of fluoroquinolone skin phototoxicity. Toxicol in vitro 2000; 14: 275-283.

UV Measurements Related to Artificial Tanning Units. (H. Moseley – Chairman of Working Group). EU Thematic Network. UV News Issue 6 November 2000: C1-C20.

Man I, Murphy J, Ferguson J. Fluoroquinolone phototoxicity: a comparison of moxifloxacin and lomefloxacin in normal volunteers. J Antimicrob Chemother 1999; 43, Suppl. B: 77-82.

Man I, Traynor NJ, Ferguson J. Recent developments in fluoroquinolone phototoxicity. Photodermatol Photoimmunol Photomed 1999; 15: 32-33.

Ferguson J. Drug and chemical photosensitivity. In: Hawk JLM, editor. Photodermatology. London: Arnold Publishers; 1999: pp155-169.

Vousden M, Ferguson J, Richards J, Bird N, Allen A. Evaluation of phototoxic potential of gemifloxacin in healthy volunteers compared with ciprofloxacin. Chemotherapy 1999; 45: 512-520.

Ferguson J, McEwen J, Gohler K, Mignot A, Watson D. Phototoxic potential of gatifloxacin, a new fluoroquinolone antimicrobial. Drugs 1999; 58, Suppl: 397-399

Ferguson J, Dawe R. Phototoxicity in quinolones: comparison of ciprofloxacin and grepafloxacin. J Antimicrob Chemother 1997; 40, Suppl. A: 93-98.

Ferguson J. Fluoroquinolone photosensitization: a review of clinical and laboratory studies. Photochem Photobiol 1995; 62: 954-958.

Ferguson J, Johnson BE. Clinical and laboratory studies of the photosensitizing potential of norfloxacin, a 4-quinolone broad spectrum antibiotic. Br J Dermatol 1993; 128: 285-295.

Ferguson J, Johnson BE. Ciprofloxacin-induced photosensitivity: in vitro and in vivo studies. Br J Dermatol 1990; 123: 9-20.

Johnson BE, Ferguson J. Drug and chemical photosensitivity. Semin Dermatol 1990; 9: 39-46.


Web Site Launched

18th April 2008